首页|期刊导航|数字中医药(英文)|补肾活血方通过调控内皮祖细胞SIRT1/CXCL12/CXCR4/CXCR7轴对大鼠椎间盘退变及终板微循环的保护作用

补肾活血方通过调控内皮祖细胞SIRT1/CXCL12/CXCR4/CXCR7轴对大鼠椎间盘退变及终板微循环的保护作用OA

Protective effects of Bushen Huoxue Formula on intervertebral disc degeneration and endplate microcirculation in rats via the SIRT1/CXCL12/CXCR4/CXCR7 axis in endothelial progenitor cells

中文摘要英文摘要

目的 探讨补肾活血方(BSHXF)对椎间盘退变(IVDD)、软骨终板微血管重塑及内皮祖细胞(EPCs)功能的影响,以及沉默信息调节因子 1(SIRT1)/C-X-C基序趋化因子配体 12(CXCL12)/C-X-C基序趋化因子受体 4(CXCR4)/C-X-C 基序趋化因子受体 7(CXCR7)信号通路在其中的潜在作用.方法 本研究包括体内与体外实验.在体内实验中,将 24 只 4-6周龄雄性 SD大鼠分为 4组:大鼠对照组、大鼠模型组、大鼠 BSHXF 组及大鼠 EX527+BSHXF 组,每组 6 只.通过对大鼠尾部椎间盘施加约 11 N的持续轴向压缩 2周以构建 IVDD 模型.模型建立后,大鼠 BSHXF 组每日灌胃给予 BSHXF17.71 g/(kg·d);大鼠 EX527+BSHXF 组在接受相同 BSHXF 给药方案的同时,每日腹腔注射 5 mg/kg 的 SIRT1抑制剂EX527,连续干预 2 周.采用磁共振成像(MRI)、Pfirrmann分级及苏木精-伊红(HE)染色评估椎间盘退变程度;通过 CD31免疫组化染色评估终板微血管密度;利用实时荧光定量逆转录聚合酶链式反应(RT-qPCR)检测椎间盘及终板组织中 SIRT1、CXCL12、CXCR4 和 CXCR7的 mRNA 表达水平,采用蛋白质印迹法和免疫荧光染色检测其蛋白表达.在体外实验中,从另外 6只 SD 大鼠中分离培养大鼠骨髓源性 EPCs,并通过 CD34/CD133 免疫荧光染色进行鉴定.将 EPCs分为对照组、BSHXF 组、siRNA-SIRT1组、siRNA+BSHXF 组及塞来昔布组.BSHXF 相关组采用由另外 6 只 SD大鼠制备的 10%BSHXF 含药血清进行干预,并通过靶向 SIRT1 的小干扰 RNA(si-SIRT1)技术敲低 SIRT1 的表达.随后,分别采用细胞计数试剂盒-8(CCK-8)、Transwell迁移实验和 Matrigel成管实验评估 EPCs的细胞活力、迁移能力及血管形成能力.同时,通过 RT-qPCR和蛋白质印迹法检测 EPCs中 SIRT1、CXCL12、CXCR4 和 CXCR7 的 mRNA和蛋白表达水平.结果 体内实验显示,轴向压缩导致明显的椎间盘退变,表现为 T2 加权信号强度降低、椎间隙高度下降及 Pfirrmann分级达到 IV-V级.与大鼠模型组及大鼠 EX527+BSHXF 组相比,大鼠 BSHXF 组的组织学退变明显减轻,且终板微血管密度显著增加(P<0.05).此外,与大鼠模型组及大鼠 EX527 联合BSHXF 组相比,BSHXF 显著上调了椎间盘及终板组织中 SIRT1、CXCL12、CXCR4和 CXCR7 的 mRNA与蛋白表达水平(P<0.05);免疫荧光分析进一步证实了大鼠 BSHXF 组中上述标志物的高表达(P<0.05).体外实验表明,与对照组、si-SIRT1组及 si-SIRTI+BSHXF 组相比,BSHXF含药血清显著提高了 EPCs的细胞活力、迁移能力,并增加了总成管长度和分支点数量(P<0.05).BSHXF 组与塞来昔布组的成管能力无显著性差异(P>0.05).相反,敲低SIRT1则显著削弱了EPCs的血管生成相关功能,并逆转了BSHXF 对EPCs活力、迁移和成管能力的促进作用,si-SIRT1 组与 si-SIRT1+BSHXF 组之间无显著差异(P>0.05).结论 BSHXF 可减轻大鼠尾部椎间盘压缩模型中的 IVDD 相关退行性改变,增加终板微血管密度,同时在体外增强 EPCs的增殖、迁移及成管能力.BSHXF 对 IVDD 终板微循环的改善作用可能与 EPCs中 SIRT1介导的 CXCL12/CXCR4/CXCR7 信号轴调控有关.

Objective To investigate the efficacy of the Bushen Huoxue Formula(补肾活血方,BSHXF)in alleviating intervertebral disc degeneration(IVDD),improving endplate microcirculation,and enhancing endothelial progenitor cell(EPC)function,while investigating the potential role of the sirtuin 1(SIRT1)/C-X-C motif chemokine ligand 12(CXCL12)/C-X-C motif chemokine receptor 4(CXCR4)/C-X-C motif chemokine receptor 7(CXCR7)signaling path-way. Methods This study comprised both in vivo and in vitro experiments.In vivo,24 male Sprague-Dawley(SD)rats(4-6 weeks old)were used,and allocated into four groups(n=6 per group):Rat-Control,Rat-Model,Rat-BSHXF,and Rat-EX527+BSHXF groups.IVDD was induced by applying continuous axial compression(approximately 11 N)to the caudal inter-vertebral discs for two weeks.Following model establishment,rats in the Rat-BSHXF group received oral BSHXF at 17.71 g/(kg·d)once daily,whereas those in the Rat-EX527+BSHXF group received the SIRT1 inhibitor EX527 at 5 mg/kg by intraperitoneal injection once daily in addition to the same BSHXF regimen for two consecutive weeks.Disc degeneration was eval-uated using magnetic resonance imaging(MRI),Pfirrmann grading,and hematoxylin and eosin(HE)staining.Endplate microvascular density was assessed via CD31 immunostaining.The mRNA expression levels of SIRT1,CXCL12,CXCR4,and CXCR7 in disc and endplate tis-sues were quantified using reverse transcription quantitative polymerase chain reaction(RT-qPCR),whereas their protein expression levels were assessed using Western blot and im-munofluorescence staining.In vitro,rat bone marrow-derived EPCs were isolated from a sep-arate cohort of six SD rats,cultured,and identified via CD34/CD133 immunofluorescence staining.The EPCs were allocated into Control,BSHXF,si-SIRT1,si-SIRT1+BSHXF,and Celecoxib groups.Cells in the BSHXF-related groups were treated with 10%BSHXF-contain-ing serum prepared using another separate cohort of six SD rats,and SIRT1 knockdown was achieved using SIRT1 targeting small interfering RNA(si-SIRT1).EPC viability,migration,and tube formation were evaluated using cell counting kit-8(CCK-8),transwell migration,and Matrigel tube formation assays,respectively.Additionally,the mRNA and protein expression levels of SIRT1,CXCL12,CXCR4,and CXCR7 in EPCs were measured via RT-qPCR and West-ern blot,respectively. Results In vivo,axial compression induced significant disc degeneration,characterized by reduced T2 signal intensity,decreased disc height,and Pfirrmann grade IV-V changes.Compared with the Rat-Model and Rat-EX527+BSHXF groups,the Rat-BSHXF group exhibit-ed less severe histological degeneration and significantly increased endplate microvascular density(P<0.05).Furthermore,BSHXF significantly upregulated the mRNA and protein ex-pression levels of SIRT1,CXCL12,CXCR4,and CXCR7 in disc and endplate tissues compared with both the Rat-Model and Rat-EX527+BSHXF groups(P<0.05).These elevated expres-sion levels in the Rat-BSHXF group were further corroborated by immunofluorescence analy-sis(P<0.05).In vitro,treatment with BSHXF-containing serum significantly enhanced EPC viability,migration,total tube length,and branch point formation compared with the Control,si-SIRT1,and si-SIRT1+BSHXF groups(P<0.05).No significant differences in tube forma-tion were observed between the BSHXF and Celecoxib groups(P>0.05).Conversely,SIRT1 knockdown markedly impaired EPCs angiogenesis-related functions and abrogated the BSHXF-induced enhancements in EPCs viability,migration,and tube formation,with no sig-nificant differences observed between the si-SIRT1 and si-SIRT1+BSHXF groups(P>0.05). Conclusion BSHXF attenuated IVDD-related degenerative changes and increased endplate microvascular density in a rat model of caudal disc compression,while enhancing EPC viabil-ity,migration,and angiogenesis in vitro.These findings suggest that the effects of BSHXF on endplate microcirculation during IVDD may be associated with the SIRT1-related modula-tion of the CXCL12/CXCR4/CXCR7 axis in EPCs.

杨升祺;申展;翟伟峰;谢越;贾永伟;郭际

上海中医药大学附属光华医院脊柱外科,上海 200052,中国||上海市中医药研究院中西医结合关节炎研究所,上海 200052,中国||上海健康医学院附属周浦医院骨科,上海 201318,中国||上海中医药大学研究生院,上海 201203,中国上海中医药大学附属光华医院脊柱外科,上海 200052,中国||上海市中医药研究院中西医结合关节炎研究所,上海 200052,中国||上海健康医学院附属周浦医院骨科,上海 201318,中国||上海中医药大学研究生院,上海 201203,中国上海健康医学院附属周浦医院骨科,上海 201318,中国上海中医药大学附属光华医院脊柱外科,上海 200052,中国||上海市中医药研究院中西医结合关节炎研究所,上海 200052,中国||上海健康医学院附属周浦医院骨科,上海 201318,中国||上海中医药大学研究生院,上海 201203,中国上海中医药大学附属光华医院脊柱外科,上海 200052,中国||上海健康医学院附属周浦医院骨科,上海 201318,中国上海中医药大学附属光华医院脊柱外科,上海 200052,中国||上海市中医药研究院中西医结合关节炎研究所,上海 200052,中国

椎间盘退变补肾活血方终板微循环内皮祖细胞SIRT1/CXCL12/CXCR4/CXCR7轴

Intervertebral disc degenerationBushen Huoxue FormulaEndplate microcirculationEndothelial progenitor cellsSIRT1/CXCL12/CXCR4/CXCR7 axis

《数字中医药(英文)》 2026 (3)

397-411,15

National Natural Science Foundation of China(82575112 and 82304955),and Shanghai Pudong New Area Science and Technology Development Fund,Public Institution Livelihood Research Special Project(PKJ2024-Y47).

10.1016/j.dcmed.2026.08.007

评论